For the study, investigators examined volatile organic compounds in breath samples from patients with localized and metastatic pancreatic cancers, compared with patients with benign pancreatic disease and some with a normal pancreas. Tests identified 12 compounds that were indicative of pancreatic cancer. These compounds were from three main chemical groups, namely aldehydes, alkanes and alcohols. Read more . . .
Pancreatic cancer carries a very poor prognosis as most patients are diagnosed at an advanced stage. Now a new BJS (British Journal of Surgery) study indicates that breath analyses may help detect pancreatic cancer earlier, when curative treatments may be possible.